ESR1 and breast cancer: The above data may be taken to suggest that the modulation of expression of uniquely regulated genes in ERβ1- and ERβ2-expressing MCF7 cells by OHT in combination with ATRA is in accordance with ERβ1 being a marker of responsiveness and ERβ2 being a marker of resistance of ERα-positive BC cells to the combinatorial treatment.